- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
North America
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Latin America
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Europe
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Germany
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Japan
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United States
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- February 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2025
- 10 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2021
- 86 Pages
Global
€4533EUR$4,750USD£3,798GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- May 2022
- 210 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- April 2022
- 220 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- March 2022
- 172 Pages
Global
From €3543EUR$3,712USD£2,968GBP

The Defibrillator market is a segment of the Cardiovascular Devices industry. Defibrillators are medical devices used to restore normal heart rhythm in patients suffering from cardiac arrhythmias. These devices are used in both in-hospital and out-of-hospital settings, and are typically used in emergency situations. Defibrillators can be divided into two main categories: implantable and external. Implantable defibrillators are surgically implanted into the patient's chest, while external defibrillators are used externally and are typically used in emergency situations.
Defibrillators are used to treat a variety of cardiac conditions, including ventricular fibrillation, ventricular tachycardia, and atrial fibrillation. The market for defibrillators is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the increasing demand for home-based defibrillators.
Some of the major companies in the Defibrillator market include Medtronic, St. Jude Medical, Biotronik, Boston Scientific, and Philips Healthcare. Show Less Read more